Nicotine vaping during adolescence may leave a lasting imprint on the brain's reward system, driving nicotine-seeking behavior well into adulthood even after long stretches without any exposure, according to new research ...
23 hours ago
0
3
Mamadou Tahirou is 18 but looks more like a 12-year-old. His frame is frail from the ravages of sickle cell disease, which one Senegalese laboratory hopes to attenuate with affordable drug production.
Aug 26, 2026
0
5
Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him ...
Aug 24, 2026
0
6
Cancer is the second-leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come ...
Aug 24, 2026
0
4
Peter Mac researchers have identified potential new drug targets for pancreatic cancer by uncovering proteins cancer cells rely on to grow and survive.
Aug 24, 2026
0
8
Fire and medical officials have issued warnings about a supplement offered to Western wildland firefighters who have been exposed to toxic chemicals while battling some of the country's biggest blazes.
Aug 23, 2026
0
6
What if we could fight cancer by specifically activating a key enzyme instead of deactivating it? That's exactly what a research team at Marburg University has achieved for the first time with the enzyme PRMT1. The scientists ...
Aug 21, 2026
0
2
China has become an increasingly important contributor to pharmaceutical development, but comparatively little attention has been paid to how successfully medicines developed in China have entered major international markets.
Aug 21, 2026
0
5
Connecting people with clinical trials is complicated—even if people identify a promising match, there's a slew of potentially thorny factors, including geographic incompatibility and financial and time considerations.
Aug 20, 2026
0
4
Congo will receive 70,000 doses of the Ervebo vaccine, which has been effective in past Ebola outbreaks, the World Health Organization and partners said Thursday, announcing a step seen as a major boost to efforts to contain ...
Aug 20, 2026
0
1
